David Juergen Wustrow

USPTO Granted Patents = 29 (Patent Applications = 23)

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 5 (Patent Applications = 2)

Average Co-Inventor Count = 4.9

ph-index = 5

Forward Citations = 94(Granted Patents)

Location History:

Saratoga, CA (US) (2013)
Los Gatos, CA (US) (2015 - 2022)
South San Francisco, CA (US) (2024)

Company Filing History:

12 out of 13

Rapt Therapeutics, Inc.

patents

6 out of 7

Cleave Biosciences, Inc.

Arbor Pharmaceuticals, LLC

Years Active: 2013-2025

Loading Chart...

29 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12428393 - Methods of making trans isomeric forms of G protein-coupled receptor modulators (2025-09-30),

2. 12240837 - Chemokine receptor modulators and uses thereof (2025-03-04),

3. 12098139 - Chemokine receptor modulators and uses thereof (2024-09-24),

4. 12006318 - Crystalline forms of C-C chemokine receptor type 4 antagonist and uses thereof (2024-06-11),

5. 11918582 - Pyrazole pyrimidine compounds and uses thereof (2024-03-05),

6. 11384064 - Chemokine receptor modulators and uses thereof (2022-07-12),

7. 11192879 - Chemokine receptor modulators and uses thereof (2021-12-07),

8. 11084829 - Ubiquitin-specific-processing protease 7 (USP7) modulators and uses thereof (2021-08-10),

9. 11046699 - Pyrazolo-pyrimidin-amino-cycloalkyl compounds and their therapeutic uses (2021-06-29),

10. 10940117 - Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof (2021-03-09),

11. 10722514 - Ubiquitin-specific-processing protease 7 (USP7) modulators and uses thereof (2020-07-28),

12. 10716760 - Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof (2020-07-21),

13. 10683280 - Chemokine receptor modulators and uses thereof (2020-06-16),

14. 10604526 - Chemokine receptor modulators and uses thereof (2020-03-31),

15. 10246462 - Chemokine receptor modulators and uses thereof (2019-04-02),

Title: David Juergen Wustrow: A Leader in Chemokine Modulation Innovations

Introduction: David Juergen Wustrow, a prominent inventor based in Los Gatos, California, holds an impressive portfolio of 28 patents. His innovative work primarily focuses on chemokine receptor modulators, contributing significantly to advancements in therapeutic applications.

Latest Patents: Among his latest patents are groundbreaking inventions related to chemokine receptor modulators. These patents disclose compounds and methods for modulating certain chemokine receptor activity, highlighting his ongoing commitment to improving biopharmaceutical solutions.

Career Highlights: David has made noteworthy contributions to the biotech industry through his work at renowned companies such as Rapt Therapeutics, Inc. and Cleave Biosciences, Inc. His experience and expertise have led to significant advancements in understanding chemokine receptors and their potential therapeutic uses.

Collaborations: Throughout his career, David has collaborated with distinguished colleagues, including Mikhail Zibinsky and Jeffrey J. Jackson. These collaborations have further propelled innovations in the field of chemokine modulation and have facilitated the development of new therapeutic strategies.

Conclusion: With 28 patents to his name, David Juergen Wustrow is a leading figure in the field of chemokine receptor modulation. His work not only demonstrates his inventive prowess but also underscores the importance of collaboration in driving forward scientific innovations in biomedicine.

This text is generated by artificial intelligence and may not be accurate.